NCT06737757View on ClinicalTrials.gov

Clinical Trial Evaluating the Safety and Efficacy of Artificial Polymer Heart Valve for the Treatment of Aortic Valve Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2029

Conditions
Aortic Valve StenosisAortic Valve DiseaseAortic Valve Regurgitation
Interventions
DEVICE

Artificial polymer heart valves

The experimental group will use polymer material surgical aortic valves(PoliaValve, Hearthill Medical) for aortic valve replacement

DEVICE

Bovine pericardial aortic valve

The control group will undergo aortic valve replacement using bovine pericardial aortic valve

All Listed Sponsors
lead

Suzhou Hearthill Medical Technology Co.,LTD

INDUSTRY

NCT06737757 - Clinical Trial Evaluating the Safety and Efficacy of Artificial Polymer Heart Valve for the Treatment of Aortic Valve Disease | Biotech Hunter | Biotech Hunter